Bausch Health Announces 2026 Annual Meeting of Shareholder Results

Executive Summary

• Bausch Health shareholders elected all 10 director nominees at the 2026 Annual Meeting of Shareholders.
• Dr. Eiry W. Roberts was elected as a new director and will serve as chair of the Science and Technology Committee.
• Shareholders approved executive compensation (non-binding advisory vote), the appointment of PricewaterhouseCoopers LLP as auditor, and authorization for the board to fix auditor remuneration.

Key Details

• Director Election Results:
  • Thomas J. Appio: 196,814,621 For
  • Christian A. Garcia: 196,711,908 For
  • Michael Goettler: 196,757,828 For
  • Sarah B. Kavanagh: 188,459,870 For
  • Frank D. Lee: 183,885,617 For
  • Sandra Leung: 195,931,772 For
  • John A. Paulson: 196,214,806 For
  • Robert N. Power: 186,236,066 For
  • Eiry W. Roberts, M.D.: 196,972,752 For (New Director)
  • Amy B. Wechsler, M.D.: 195,813,955 For
• New Director Profile: Dr. Eiry W. Roberts brings expertise in clinical development, medical strategy, and business development; she previously served as Chief Medical Officer of Neurocrine Biosciences, Inc.
• Auditor Appointment: PricewaterhouseCoopers LLP was appointed to serve as the Company's auditor until the close of the 2027 Annual Meeting of Shareholders.
• Other Approvals: Shareholders approved the non-binding advisory vote on compensation for named executive officers and authorized the board of directors to fix the auditor's remuneration.